Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Nov 7, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences, Inc.
| -5.00K |
$91.28 | -$456,400.00 | -6.40% | 73.13K |
Nov 6
|
Scheduled
| ||||||
Gilead Sciences, Inc.
| -590.00 |
$74.71 | -$893,485.00 | -0.59% | 99.6K |
Nov 6
|
Scheduled
| ||||||
Gilead Sciences, Inc.
| 272 |
$89.00 | -$21,538.00 | +1.31% | 20.98K | +1 |
Oct 25
| ||||||
Gilead Sciences, Inc.
| 3.75K |
$71.21 | -$347,287.00 | +3.81% | 102.19K |
Sep 12
|
Scheduled
| ||||||
Gilead Sciences, Inc.
| -29.36K |
$83.78 | -$2,459,576.75 | -27.31% | 78.13K |
Sep 12
|
Scheduled
| ||||||
Gilead Sciences, Inc.
| 332 |
$81.44 | -$25,002.08 | +1.63% | 20.71K | +1 |
Sep 10
| ||||||
Gilead Sciences, Inc.
| 609 |
$81.44 | -$23,780.48 | +1.69% | 36.59K | +1 |
Sep 10
| ||||||
Gilead Sciences, Inc.
| 2.06K |
$81.44 | -$143,823.04 | +2.13% | 98.44K |
Sep 10
| |||||||
Gilead Sciences, Inc.
| 5.55K |
$81.44 | -$386,758.56 | +1.13% | 496K |
Sep 10
| |||||||
Gilead Sciences, Inc.
| 2.02K |
$81.44 | -$141,216.96 | +1.91% | 107.48K |
Sep 10
| |||||||
Gilead Sciences, Inc.
| 1.96K |
$81.44 | -$136,982.08 | +1.43% | 138.92K |
Sep 10
| |||||||
Gilead Sciences, Inc.
| -9.51K |
$78.03 | -$742,299.39 | -8.27% | 105.47K |
Aug 28
|
Scheduled
| ||||||
Gilead Sciences, Inc.
| -5.49K |
$73.98 | -$406,150.20 | -4.56% | 114.98K |
Aug 13
|
Scheduled
| ||||||
Gilead Sciences, Inc.
| 2.7K |
$73.66 | -$72,186.80 | +8.11% | 35.98K | +1 |
Aug 10
| ||||||
Gilead Sciences, Inc.
| 5.83K |
$76.51 | -$223,179.67 | +40.05% | 20.38K | +1 |
Jul 25
| ||||||
Gilead Sciences, Inc.
| -2.00K |
$68.63 | -$137,260.00 | -2.03% | 96.38K |
Jul 1
|
Scheduled
| ||||||
Gilead Sciences, Inc.
| 1.98K |
$65.25 | -$108,445.50 | +1.46% | 136.96K |
Jun 10
| |||||||
Gilead Sciences, Inc.
| 646 |
$65.25 | -$16,638.75 | +1.98% | 33.28K | +1 |
Jun 10
| ||||||
Gilead Sciences, Inc.
| 5.6K |
$65.25 | -$306,218.25 | +1.16% | 490.45K |
Jun 10
| |||||||
Gilead Sciences, Inc.
| 2.04K |
$65.25 | -$111,838.50 | +1.72% | 120.47K |
Jun 10
| |||||||
Gilead Sciences, Inc.
| 2.08K |
$65.25 | -$113,796.00 | +2.16% | 98.38K |
Jun 10
| |||||||
Gilead Sciences, Inc.
| 434 |
$65.25 | -$13,311.00 | +3.07% | 14.55K | +1 |
Jun 10
| ||||||
Gilead Sciences, Inc.
| 2.31K |
—
|
—
| +10.39% | 24.54K |
May 8
| |||||||
Gilead Sciences, Inc.
| 2.31K |
—
|
—
| +451.17% | 2.82K |
May 8
| |||||||
Gilead Sciences, Inc.
| 2.31K |
—
|
—
| +27.53% | 10.7K |
May 8
| |||||||
Gilead Sciences, Inc.
| 2.31K |
—
|
—
| +29.16% | 10.23K |
May 8
| |||||||
Gilead Sciences, Inc.
| 1.86K |
$64.92 | -$29,278.92 | +16.88% | 12.87K |
May 8
| |||||||
Gilead Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 8
| |||||||
Gilead Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 8
| |||||||
Gilead Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 8
| |||||||
Gilead Sciences, Inc.
| 357 |
$65.27 | -$10,312.66 | +2.60% | 14.11K | +1 |
Apr 25
| ||||||
Gilead Sciences, Inc.
| -2.00K |
$72.96 | -$145,920.00 | -2.03% | 96.3K |
Apr 1
|
Scheduled
| ||||||
Gilead Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 28
| |||||||
Gilead Sciences, Inc.
| 1.71K |
$75.12 | -$63,551.52 | +14.18% | 13.76K | +1 |
Mar 10
| ||||||
Gilead Sciences, Inc.
| 1.89K |
$75.12 | -$59,344.80 | +6.15% | 32.63K | +1 |
Mar 10
| ||||||
Gilead Sciences, Inc.
| 5.6K |
$75.12 | -$360,801.36 | +6.04% | 98.3K |
Mar 10
| |||||||
Gilead Sciences, Inc.
| 16.16K |
$75.12 | -$1,035,303.84 | +3.45% | 484.85K |
Mar 10
| |||||||
Gilead Sciences, Inc.
| 5.29K |
$75.12 | -$342,472.08 | +4.67% | 118.43K |
Mar 10
| |||||||
Gilead Sciences, Inc.
| 5.23K |
$75.12 | -$338,415.60 | +4.03% | 134.98K |
Mar 10
| |||||||
Gilead Sciences, Inc.
| -10.23K |
$72.82 | -$744,983.86 | -9.94% | 92.71K |
Feb 28 - Feb 29
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.